From BigGo Finance · BigGo Finance · · 1m
Fosun Pharma Q3 Revenue Exceeds CNY 30 Billion
Fosun Pharma's first three quarters revenue hits CNY 30.463 billion, with innovative drug revenue up 15.54% year-over-year.
In brief
Fosun Pharma's first three quarters revenue hits CNY 30.463 billion, with innovative drug revenue up 15.54% year-over-year. Fosun Pharma reported first three quarters revenue of CNY 30.463 billion, up 3.64% year-over-year, with innovative drug revenue growing 15.54%. Originally reported by BigGo Finance.
First Three Quarters Revenue
Fosun Pharma reported first three quarters revenue of CNY 30.463 billion, up 3.64% year-over-year.
Net Profit Growth
Net profit attributable to shareholders rose to CNY 2.667 billion, up 5.71% year-over-year.
Innovative Drug Revenue
Innovative drug revenue grew 15.54% year-over-year, accounting for 35.43% of pharmaceutical business revenue.
Overseas Business Expansion
Overseas business revenue grew 11.62% year-over-year, increasing its share of group revenue to 30.96%.
R&D Investment Surge
Total R&D investment reached CNY 5.247 billion, up 31.24% year-over-year, with innovative drugs accounting for 82.83%.
Third-Quarter Performance
Third-quarter revenue was CNY 10.02 billion with net profit of CNY 946 million, up 15.18% year-over-year.
What matters most
Fosun Pharma reported first three quarters revenue of CNY 30.463 billion, up 3.64% year-over-year, with innovative drug revenue growing 15.54%.
